Six-minute walk test in Chagas cardiomyopathy

Area of Science:

• Cardiology
• Clinical Medicine
• Parasitology

Background:

• Chagas disease often leads to cardiomyopathy, impacting patient prognosis.
• Assessing functional capacity is crucial for managing Chagas disease patients.
• The six-minute walk test (6MWT) is a widely used measure of submaximal exercise capacity.

Discussion:

• This study systematically evaluated the six-minute walk test (6MWT) in Chagas disease for the first time.
• Investigated correlations between 6MWT performance and established biomarkers of cardiac strain and dysfunction.
• Explored the relationship between functional capacity and the severity of Chagas disease cardiomyopathy.

Key Insights:

• Six-minute walk test (6MWT) distance negatively correlated with monocyte chemoattractant protein-1 (MCP-1) and natriuretic peptide type B (BNP) levels.
• Shorter 6MWT distances were associated with greater ejection fraction deterioration, indicating poorer cardiac function.
• Submaximal functional capacity, as measured by 6MWT, reflects the severity of Chagas disease cardiomyopathy.

Outlook:

• The six-minute walk test (6MWT) shows promise as an accessible auxiliary tool for clinical status evaluation in Chagas disease.
• Further research can validate 6MWT as a prognostic indicator in Chagas disease management.
• Integrating 6MWT into routine clinical practice could improve patient monitoring and therapeutic strategies.